$TECH BIO-TECHNE Corp Insider Trading Week 44/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIO-TECHNE Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIO-TECHNE Corp in week 44/2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 03 2017 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Option Exercise | M | 63.03 | 5,000 | 315,150 | 0 | ||
Nov 03 2017 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Sell | S | 130.18 | 5,000 | 650,907 | 7,712 | 12.7 K to 7.7 K (-39.33 %) | |
Nov 03 2017 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Buy | M | 63.03 | 5,000 | 315,150 | 12,712 | 7.7 K to 12.7 K (+64.83 %) | |
Oct 31 2017 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Option Exercise | A | 125.05 | 3,125 | 390,781 | 3,125 | ||
Oct 31 2017 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Grant | A | 0.00 | 739 | 0 | 739 | 0 to 739 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 125.05 | 78,228 | 9,782,411 | 78,228 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 125.05 | 117,342 | 14,673,617 | 117,342 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | A | 0.00 | 21,291 | 0 | 21,291 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Grant | A | 0.00 | 14,194 | 0 | 84,472 | 70.3 K to 84.5 K (+20.20 %) |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Seth Alpna | Option Exercise | A | 125.05 | 3,125 | 390,781 | 3,125 | ||
Oct 30 2017 | TECH | BIO-TECHNE Corp | Seth Alpna | Grant | A | 0.00 | 739 | 0 | 739 | 0 to 739 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Option Exercise | A | 125.05 | 3,125 | 390,781 | 3,125 | ||
Oct 30 2017 | TECH | BIO-TECHNE Corp | STEER RANDOLPH C | Grant | A | 0.00 | 739 | 0 | 3,712 | 3 K to 3.7 K (+24.86 %) | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Bazan J. Fernando | Chief Technical Off ... | Option Exercise | A | 125.05 | 12,119 | 1,515,481 | 12,119 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Bazan J. Fernando | Chief Technical Off ... | Option Exercise | A | 125.05 | 9,089 | 1,136,579 | 9,089 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Bazan J. Fernando | Chief Technical Off ... | Option Exercise | A | 0.00 | 1,649 | 0 | 1,649 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Option Exercise | A | 125.05 | 3,125 | 390,781 | 3,125 | ||
Oct 30 2017 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Grant | A | 0.00 | 739 | 0 | 7,712 | 7 K to 7.7 K (+10.60 %) | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 125.05 | 12,670 | 1,584,384 | 12,670 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 125.05 | 9,503 | 1,188,350 | 9,503 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 0.00 | 1,724 | 0 | 1,724 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Sen. VP Protein Pla ... | Option Exercise | A | 125.05 | 14,323 | 1,791,091 | 14,323 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Sen. VP Protein Pla ... | Option Exercise | A | 125.05 | 10,742 | 1,343,287 | 10,742 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Gavin Robert M. | Sen. VP Protein Pla ... | Option Exercise | A | 0.00 | 1,949 | 0 | 1,949 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Gould Kevin S | SVP Clinical Contro ... | Option Exercise | A | 125.05 | 14,323 | 1,791,091 | 14,323 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Gould Kevin S | SVP Clinical Contro ... | Option Exercise | A | 125.05 | 10,742 | 1,343,287 | 10,742 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Gould Kevin S | SVP Clinical Contro ... | Option Exercise | A | 0.00 | 1,949 | 0 | 1,949 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | A | 125.05 | 15,976 | 1,997,799 | 15,976 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | A | 125.05 | 11,982 | 1,498,349 | 11,982 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Eansor Norman David | SVP - Novus Biologi ... | Option Exercise | A | 0.00 | 2,174 | 0 | 2,174 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 125.05 | 32,613 | 4,078,256 | 32,613 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 125.05 | 24,460 | 3,058,723 | 24,460 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 0.00 | 4,438 | 0 | 4,438 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Option Exercise | A | 125.05 | 3,125 | 390,781 | 3,125 | ||
Oct 30 2017 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Grant | A | 0.00 | 739 | 0 | 3,012 | 2.3 K to 3 K (+32.51 %) | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Nusse Roeland | Option Exercise | A | 125.05 | 3,125 | 390,781 | 3,125 | ||
Oct 30 2017 | TECH | BIO-TECHNE Corp | Nusse Roeland | Grant | A | 0.00 | 739 | 0 | 4,712 | 4 K to 4.7 K (+18.60 %) | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Option Exercise | A | 125.05 | 3,125 | 390,781 | 3,125 | ||
Oct 30 2017 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Grant | A | 0.00 | 739 | 0 | 4,212 | 3.5 K to 4.2 K (+21.28 %) | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Option Exercise | A | 125.05 | 3,125 | 390,781 | 3,125 | ||
Oct 30 2017 | TECH | BIO-TECHNE Corp | Dinarello Charles A | Grant | A | 0.00 | 739 | 0 | 8,212 | 7.5 K to 8.2 K (+9.89 %) |